Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male

NCT01404598 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: naproxcinod 750 bid
DRUG: naproxcinod 3000 mg od
DRUG: naproxen 500 mg bid

Sponsor

NicOx